These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21425309)
1. Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis? Vlachogiannakos J; Daikos G; Thalheimer U; Burroughs AK; Ladas SD Hepatology; 2011 Jun; 53(6):2140-1; author reply 41-2. PubMed ID: 21425309 [No Abstract] [Full Text] [Related]
2. Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial. Kimer N; Pedersen JS; Tavenier J; Christensen JE; Busk TM; Hobolth L; Krag A; Al-Soud WA; Mortensen MS; Sørensen SJ; Møller S; Bendtsen F; J Gastroenterol Hepatol; 2018 Jan; 33(1):307-314. PubMed ID: 28671712 [TBL] [Abstract][Full Text] [Related]
3. Is bacterial DNA a surrogate marker of bacterial translocation in cirrhosis? Fujita T J Hepatol; 2008 Jul; 49(1):145-6; author reply 146-7. PubMed ID: 18466995 [No Abstract] [Full Text] [Related]
4. Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study. Thalheimer U; De Iorio F; Capra F; del Mar Lleo M; Zuliani V; Ghidini V; Tafi MC; Caburlotto G; Gennari M; Burroughs AK; Vantini I Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1228-34. PubMed ID: 20512041 [TBL] [Abstract][Full Text] [Related]
5. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis. Francés R; González-Navajas JM; Zapater P; Muñoz C; Caño R; Pascual S; Márquez D; Santana F; Pérez-Mateo M; Such J J Clin Immunol; 2007 Jul; 27(4):438-44. PubMed ID: 17404822 [TBL] [Abstract][Full Text] [Related]
6. Association of markers of bacterial translocation with immune activation in decompensated cirrhosis. Mortensen C; Jensen JS; Hobolth L; Dam-Larsen S; Madsen BS; Andersen O; Møller S; Bendtsen F Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1360-6. PubMed ID: 25357217 [TBL] [Abstract][Full Text] [Related]
7. Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis. Usui S; Ebinuma H; Chu PS; Nakamoto N; Yamagishi Y; Saito H; Kanai T BMC Gastroenterol; 2017 Oct; 17(1):106. PubMed ID: 29041907 [TBL] [Abstract][Full Text] [Related]
8. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Bellot P; Francés R; Such J Liver Int; 2013 Jan; 33(1):31-9. PubMed ID: 23121656 [TBL] [Abstract][Full Text] [Related]
9. Infection as a Trigger for Portal Hypertension. Steib CJ; Schewe J; Gerbes AL Dig Dis; 2015; 33(4):570-6. PubMed ID: 26159275 [TBL] [Abstract][Full Text] [Related]
10. The impact of rifaximin in the prevention of bacterial infections in cirrhosis. Mariani M; Zuccaro V; Patruno SF; Scudeller L; Sacchi P; Lombardi A; Vecchia M; Columpsi P; Marone P; Filice G; Bruno R Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):1151-1158. PubMed ID: 28338174 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study on effect of qihuang oral liquid to enteric flora disturbance and serum endotoxin level in patients of liver cirrhosis]. Jia DX; Xu L; Su F Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jul; 21(7):495-7. PubMed ID: 12575390 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection. Bruns T; Reuken PA; Stengel S; Gerber L; Appenrodt B; Schade JH; Lammert F; Zeuzem S; Stallmach A Liver Int; 2016 Aug; 36(8):1133-42. PubMed ID: 26901072 [TBL] [Abstract][Full Text] [Related]
13. Detection of ascitic fluid infections in patients with liver cirrhosis and ascites. Mostafa MS; El-Seidi EA; Kassem AM; Shemis MA; Saber M; Michael MN Arab J Gastroenterol; 2011 Mar; 12(1):20-4. PubMed ID: 21429450 [TBL] [Abstract][Full Text] [Related]
14. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. Kaji K; Takaya H; Saikawa S; Furukawa M; Sato S; Kawaratani H; Kitade M; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H World J Gastroenterol; 2017 Dec; 23(47):8355-8366. PubMed ID: 29307995 [TBL] [Abstract][Full Text] [Related]
15. Endotoxin measures in patients' sample: how valid are the results? Stadlbauer V; Davies NA; Wright G; Jalan R J Hepatol; 2007 Nov; 47(5):726-7; author reply 727-3. PubMed ID: 17850915 [No Abstract] [Full Text] [Related]
16. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404 [TBL] [Abstract][Full Text] [Related]